Skip to content

Clinical trials

Completed Hematologic Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Status: Completed Country / region: United States Clear all

382 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20012
20028
200310
20048
200512
200610
200716
200820
200917
201017
201119
201220
201322
201414
201522
201621
201712
201810
201913
202024
202138
202215
20234
20248

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed382

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center35
National Cancer Institute (NCI)18
Fred Hutchinson Cancer Center14
Duke University11
St. Jude Children's Research Hospital11
Dana-Farber Cancer Institute10
Novartis Pharmaceuticals10
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University9
University of California, San Francisco8
City of Hope Medical Center7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms382
Leukemia60
Lymphoma60
Multiple Myeloma57
Leukemia, Myeloid, Acute55
Myelodysplastic Syndromes55
Precursor Cell Lymphoblastic Leukemia-Lymphoma46
Neoplasms42
Lymphoma, Non-Hodgkin41
Hodgkin Disease39

Trials

Showing 1 to 25 of 382. Each trial links to its page on Pharma Observatory.

282 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.